US company receives more money to develop corona vaccine
US biotech company Madrina says it has received additional funding from the US government that will allow it to complete the final phase of its coronavirus vaccine development soon.
Madrina received 48 483 million in funding from the US Federal Bureau of Investigation in April, when the Madrina vaccine was in the early stages of development and testing.
The chief executive officer of the agency said that the data obtained from the initial stages suggest that the vaccine will not only help control the current status of the coronavirus but will also play an effective role in the future against any epidemic.
So far, Madrina has received 95 955 million in funding from the US government.
Madrina says it can currently make 500 million doses of the vaccine a year and hopes to make 1 billion doses a year by the beginning of 2021.